PhRMA sues Trump administration over Medicare GLOBE drug-pricing rule
Source published: Oct 7, 2026 · 10:46 AM EDT · Event: 2026-10-07
Reuters reports that PhRMA, the pharmaceutical industry's trade group, sued the Trump administration October 7 in federal court in Washington over the Medicare GLOBE drug-pricing rule. PhRMA argues that CMS exceeded its authority to test payment models. Pharmaceutical Commerce reports that the group seeks to have the rule declared unlawful and vacated. Those are the plaintiff's claims and requested relief, not judicial findings.
Response / context
CMS's September 30 announcement says GLOBE will test international-price benchmarks for rebates on selected clinician-administered Medicare Part B drugs, aiming to lower costs while preserving care and innovation. In the October 2 final rule, CMS defends its statutory model-testing authority and says the program is limited in scope and duration. The official Federal Register sets November 30, 2026 as the regulation's effective date; voluntary manufacturer data collection starts January 1, 2027, and the performance period starts April 1, 2027. A lawsuit does not itself suspend a rule. The complaint was not independently retrieved in this review; its filing and claims are attributed to the cited reporting. No ruling on this suit is identified in those sources.
Dates and scope
Source publication: Oct 7, 2026 · 10:46 AM EDT
Event or conduct: 2026-10-07. PhRMA filed suit October 7, according to Reuters. The challenged rule was published October 2; the lawsuit is new, not the rule.
Dated report. Publication, event and review times are different; the review time is when the sources were last checked, not a live update.
This brief preserves the available response and disposition. Coverage is non-exhaustive. How we review sources.
Read the original sources
- Reuters: Pharma lobby sues Trump administration over Medicare drug price cuts ↗
Authoritative reporting on the October 7 filing and PhRMA's claims; not the complaint itself
- Government Publishing Office / Federal Register: Global Benchmark for Efficient Drug Pricing (GLOBE) Model, 91 FR 62936, October 2, 2026 ↗
Primary official rule: CMS's authority defense, scope and effective and implementation dates
- Centers for Medicare & Medicaid Services: CMS Finalizes New Mandatory Drug Payment Model to Deliver Lower Drug Prices for Beneficiaries in Original Medicare Part B ↗
Primary September 30 announcement of CMS's policy rationale, not a response issued after the lawsuit
- Pharmaceutical Commerce: Why PhRMA Sued to Block Medicare's GLOBE Pricing Model ↗
October 7 reporting on requested relief and the trade group's position
Keep following this record
The Pardon Ledger is a free weekly email: new clemency grants and money entries, each with its sources, the response on record, and what changed.
Latest issue: Whose names are on the filings ↗
Or follow @innercircleledger.com on Bluesky and @PardonLedger on X · Support the Ledger · Download the data